Outlook
- Targeting S. aureus or its communication system as leverage
point for local AE treatment
- S. aureus vaccines could improve the patient situation
- Efficacy of AE prevention e.g. with emollients and pre- and probiotics
is still controversial but could be an essential tool to stop the
atopic march
- Investigation of active modulation of the skin barrier (e.g. pH) and
the immune system (e.g. Vitamin D3, sport, food) should be in focus
- Time frame and trigger factors for AE development must be further
investigated